ASCO Genitourinary Cancers Symposium 2027
ASCO Genitourinary Cancers Symposium 2027 takes place on 11–13 February 2027 at Moscone Center, San Francisco. B2DB lists 20 speakers and 32 sessions announced so far.
The ASCO Genitourinary Cancers Symposium is a multidisciplinary meeting on the treatment of genitourinary cancers, held 11–13 February 2027 at Moscone West in San Francisco and online. It is cosponsored by the American Society of Clinical Oncology (ASCO), the American Society for Radiation Oncology (ASTRO) and the Society of Urologic Oncology (SUO), and its programme includes abstract presentations and invited speakers.
Key facts
| Dates | 11–13 February 2027 (upcoming) |
|---|---|
| Venue | Moscone Center, San Francisco, United States of America |
| Series | ASCO Genitourinary Cancers Symposium |
| Speakers | 20 |
| Sessions | 32 |
| Sponsors | 5 |
| Official site | asco.org/gu/program |
Keynote speakers
Speakers (20)
Compiled from the published agenda; speakers can claim and verify their own entry.
- Kimryn Rathmell
- Atish Dipankar Choudhury
- Baris Turkbey
- Brandon J. Manley
- Daniel Margolis
- Donna E. Hansel
- Erick M. Remer
- Hashim Uddin Ahmed
- Hikmat Al-Ahmadie
- Himisha Beltran
- Irene Tsung
- Karie Runcie
- Matthew S. Davenport
- Maximilian Diehn
- Michael J. Morris
- Mira Keyes
- Nabil Adra
- Priya Rao
- Rahul Sheth
- Surena F. Matin
Agenda (32 sessions)
Day 1 — Thursday 11 February 2027
- Oral Abstract Session: Prostate Cancer 08:05–09:45
- When Less Is More: Balancing Cancer Control and Quality of Life in the Treatment of Advanced Prostate Cancer 10:15–11:30 — Atish Dipankar Choudhury, Michael J. Morris
- Poster Session: Prostate Cancer 11:30–12:45
- Trials in Progress Poster Session: Prostate Cancer 11:30–12:45
- Breakout Session: Pathology Essentials in Rare Genitourinary Malignancies—Pearls for Clinical Decision-Making 11:40–12:40 — Hikmat Al-Ahmadie, Himisha Beltran, Nabil Adra, Priya Rao
- When Less Is More: Focal Therapy for Localized Prostate Cancer—When Is It Appropriate? 12:45–14:00 — Daniel Margolis, Hashim Uddin Ahmed, Mira Keyes
- Laying the Groundwork for GU Oncology 14:15–15:00 — Kimryn Rathmell
- Multidisciplinary Tumor Board: Navigating Discordant Data in Treatment Decision-Making for Localized and Advanced Prostate Cancer 15:30–16:45
- Rapid Oral Abstract Session: Prostate Cancer 17:00–17:45
- Trials in Progress Poster Session (Continued) with Complimentary Wine and Cheese Reception 17:45–18:45
- Poster Walks: Prostate Cancer 17:45–18:15
- Poster Session (Continued) with Complimentary Wine and Cheese Reception 17:45–18:45
Day 2 — Friday 12 February 2027
- Oral Abstract Session: Urothelial Carcinoma 08:10–09:45
- Upper Tract Urothelial Carcinoma: A Multidisciplinary Roadmap From Diagnosis to Treatment 10:15–11:30 — Erick M. Remer, Irene Tsung, Maximilian Diehn, Surena F. Matin
- Poster Session: Urothelial Carcinoma 11:30–12:45
- Trials in Progress Poster Session: Urothelial Carcinoma 11:30–12:45
- Breakout Session: Incorporating Artificial Intelligence as a Tool Into Clinical Practice 11:40–12:35 — Baris Turkbey, Donna E. Hansel
- Rapid Oral Abstract Session: Biomarkers in GU Oncology 12:45–14:00
- Multidisciplinary Tumor Board: Muscle-Invasive Bladder Cancer—Evolving Multidisciplinary Strategies 14:30–15:45
- Rapid Oral Abstract Session: Urothelial Carcinoma 16:00–16:45
- Trials in Progress Poster Session (Continued) with Complimentary Wine and Cheese Reception 16:45–17:45
- Poster Walks: Urothelial Carcinoma 16:45–17:15
- Poster Session (Continued) with Complimentary Wine and Cheese Reception 16:45–17:45
Day 3 — Saturday 13 February 2027
- Poster Session: Renal Cell Cancer; Adrenal, Testicular and Penile and Urethral Cancers 07:00–08:10
- Trials in Progress Poster Session: Renal Cell Cancer; Adrenal, Testicular and Penile and Urethral Cancers 07:00–08:10
- Oral Abstract Session: Renal Cell Cancer; Adrenal, Testicular and Penile and Urethral Cancers 08:10–09:45
- Multidisciplinary Tumor Board: Higher Than High-Risk Kidney Cancer 10:15–11:30
- Trials in Progress Poster Session (Continued) with Complimentary Boxed Lunch 11:30–12:45
- Poster Walks: Renal Cell Cancer; Adrenal, Testicular and Penile and Urethral Cancers 11:30–12:00
- Poster Session (Continued) with Complimentary Boxed Lunch 11:30–12:45
- Rapid Oral Abstract Session: Renal Cell Cancer; Adrenal, Testicular and Penile and Urethral Cancers 12:45–13:30
- Overcoming Therapy Failures in Renal Cell Carcinoma 13:45–15:00 — Brandon J. Manley, Karie Runcie, Matthew S. Davenport, Rahul Sheth
Organisers, sponsors and partners
Sponsors (5)
Astellas · AstraZeneca · Novartis · Bristol Myers Squibb · Merck
Exhibitors (43)
Artera · Tyra Biosciences, Inc. · Lantheus · Protara Therapeutics · Candel Therapeutics · Canadian Urological Association · EMD Serono · BillionToOne · Triage Cancer · Boehringer Ingelheim · BioNTech SE · Caris Life Sciences · Predicine Inc. · Kidney Cancer Association · AVEO Oncology, an LG Chem company · MiraDx · Telix Pharmaceuticals (US) Inc. · Exelixis · Clarity Pharmaceuticals · Blue Earth Diagnostics, Inc. · American Society for Radiation Oncology (ASTRO) · Dendreon Pharmaceuticals, LLC · Eli Lilly and Company · Astellas Pharma · Genentech · ImmunityBio, Inc. · ORIC Pharmaceuticals · Sumitomo Pharma America (Medical) · Exelixis Medical Affairs · Bristol Myers Squibb · Imaging Endpoints · DAVA Oncology · Exact Sciences / Oncotype · Handa Pharmaceuticals · Pfizer Canada · Amgen · Fennec Pharmaceuticals · City of Hope · American Society of Clinical Oncology · Tempus AI · The ASCO Post · Society of Urologic Oncology · Myriad Genetics
Source: the published agenda. See how B2DB compiles its records.